3H Health Investment is a Shanghai-based venture capital firm founded in 2016 that backs healthcare and life sciences companies, with a focus on biotechnology, pharmaceuticals, medical devices and HealthTech. The firm invests with a China-rooted global perspective, including activity in the United States and China, and has backed later-stage venture rounds such as Series B and Series C financings. 3H has acted as a lead investor and partners with scientists and entrepreneurs developing treatments and technologies for unmet medical needs.